Get started
ABBOTT INDIA LTD.ABBOTT INDIA LTD.ABBOTT INDIA LTD.

ABBOTT INDIA LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ABBOTINDIA chart


Full chart

ABBOTINDIA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪614.70 B‬ INR
Dividend yield (indicated)
1.12%
Price to earnings Ratio (TTM)
46.05
Basic EPS (TTM)
628.00 INR
Net income (FY)
‪12.01 B‬ INR
Revenue (FY)
‪58.49 B‬ INR
Shares float
‪5.32 M‬
Beta (1Y)
0.74

Employees


Employees (FY)
‪3.88 K‬
Change (1Y)
+29 +0.75%
Revenue / Employee (1Y)
‪15.08 M‬ INR
Net income / Employee (1Y)
‪3.10 M‬ INR

About ABBOTT INDIA LTD


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Swati Dalal
Website
abbott.co.in
Headquarters
Mumbai
Founded
1944
ISIN
INE358A01014
FIGI
BBG000CPK5R7
Abbott India Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It focuses on the therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care. The company was founded on August 22, 1944 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ABBOTINDIA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ABBOTINDIA.

Frequently Asked Questions


The current price of ABBOTINDIA is 29,413.45 INR — it has decreased by −0.42% in the past 24 hours. Watch ABBOTT INDIA LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ABBOTT INDIA LTD. stocks are traded under the ticker ABBOTINDIA.
ABBOTINDIA stock has fallen by −5.90% compared to the previous week, the month change is a −6.63% fall, over the last year ABBOTT INDIA LTD. has showed a 10.39% increase.
We've gathered analysts' opinions on ABBOTT INDIA LTD. future price: according to them, ABBOTINDIA price has a max estimate of 34,000.00 INR and a min estimate of 27,500.00 INR. Watch ABBOTINDIA chart and read a more detailed ABBOTT INDIA LTD. stock forecast: see what analysts think of ABBOTT INDIA LTD. and suggest that you do with its stocks.
ABBOTINDIA reached its all-time high on Mar 4, 2025 with the price of 31,900.00 INR, and its all-time low was 360.30 INR and was reached on Oct 29, 2003. View more price dynamics on ABBOTINDIA chart.
See other stocks reaching their highest and lowest prices.
ABBOTINDIA stock is 1.97% volatile and has beta coefficient of 0.74. Track ABBOTT INDIA LTD. stock price on the chart and check out the list of the most volatile stocks — is ABBOTT INDIA LTD. there?
Today ABBOTT INDIA LTD. has the market capitalization of ‪614.70 B‬, it has decreased by −0.91% over the last week.
Yes, you can track ABBOTT INDIA LTD. financials in yearly and quarterly reports right on TradingView.
ABBOTT INDIA LTD. is going to release the next earnings report on May 20, 2025. Keep track of upcoming events with our Earnings Calendar.
ABBOTINDIA earnings for the last quarter are 169.90 INR per share, whereas the estimation was 163.00 INR resulting in a 4.23% surprise. The estimated earnings for the next quarter are 158.00 INR per share. See more details about ABBOTT INDIA LTD. earnings.
ABBOTT INDIA LTD. revenue for the last quarter amounts to ‪16.14 B‬ INR, despite the estimated figure of ‪15.87 B‬ INR. In the next quarter, revenue is expected to reach ‪15.78 B‬ INR.
ABBOTINDIA net income for the last quarter is ‪3.61 B‬ INR, while the quarter before that showed ‪3.59 B‬ INR of net income which accounts for 0.61% change. Track more ABBOTT INDIA LTD. financial stats to get the full picture.
Yes, ABBOTINDIA dividends are paid annually. The last dividend per share was 410.00 INR. As of today, Dividend Yield (TTM)% is 1.42%. Tracking ABBOTT INDIA LTD. dividends might help you take more informed decisions.
ABBOTT INDIA LTD. dividend yield was 1.52% in 2023, and payout ratio reached 72.53%. The year before the numbers were 0.81% and 40.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 8, 2025, the company has ‪3.88 K‬ employees. See our rating of the largest employees — is ABBOTT INDIA LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT INDIA LTD. EBITDA is ‪15.96 B‬ INR, and current EBITDA margin is 25.26%. See more stats in ABBOTT INDIA LTD. financial statements.
Like other stocks, ABBOTINDIA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT INDIA LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBOTT INDIA LTD. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBOTT INDIA LTD. stock shows the buy signal. See more of ABBOTT INDIA LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.